You trust them after every carrots they have dangled over the last several years.
They spoke about multiple regulatory submissions as well and then no guidance or earnest efforts towards that anymore. They will do the same with combo trials. They will announce it and do some paperwork to trap retail bag holders but then it might not off the ground or get withdrawn due to lack of funding or dilute the hell out of the shareholders to fund this. A similar thing happened with Direct trial announcement in 2017 and then it went nowhere?
You must watch out for the social media army, who will try to justify that it only take a few million dollars and few months before the new combo trials results can be exploited to get big pharma to pay for future development and licensing. They will also try to justify that UK approval will lead to significant revenue and some of that surplus will be used to fund trials with minimal dilution.
Overall, I agree with you they will need hundreds of millions in the next 2-3 years to even do half of what they proposed. But I don’t agree with big pharma injecting cash. Rather NWBO will be diluting the shareholders in 2025 & 2026, just wait and watch.
Market Data 
Markets 
AI
